Core Business
P95 is a leading global provider of comprehensive clinical trial services, epidemiology, and real-world evidence (RWE) solutions, with a specialized focus on vaccine development and infectious diseases. Headquartered in Belgium, with regional hubs in Africa (South Africa), Latin America (Colombia), North America (USA), and Southeast Asia (Thailand), P95 operates on five continents, providing tailored clinical research solutions across 40 countries.
Our commitment to flexibility, client focus, and excellence drives us to deliver solutions that make a meaningful impact on public health worldwide.
Founded in 2011, P95 offers full-service CRO capabilities, including clinical operations, study design, data management, and biostatistics. Our mission is to be the world’s favored partner in the field of clinical research and epidemiology in support of vaccine development and use. With 300 staff and over 25 years of collective experience, P95 serves clients ranging from non-profit organizations to pharmaceutical and biotech companies throughout all stages of clinical development and post-marketing.
As part of our growth strategy, P95 has made strategic acquisitions, including Pallas Health Research and Consulting (2021), OnQ Research (2023), 4Clinics, and Assign DMB (2024), enhancing our service portfolio and strengthening our expertise in data, analysis, and writing.
P95 has been a key partner in multiple Innovative Medicines Initiative projects, including ADVANCE, DRIVE, VITAL, and COVIDRIVE, and has supported the European Commission’s Scientific Panel for Health. We are coordinating the largest public-private partnership in Europe to collect ID surveillance information and vaccine effectiveness data (id.DRIVE).
Key areas of focus
Clinical Trial Delivery, Epidemiology and Real-World Evidence, Africa and LMICs, Data Management, Statistics, Medical Writing, Early clinical phases, late phase iv, pharmacovigilance, safety, project management
Legal Representative
Legal representative:
Thomas Verstraeten